Association of hematopoietic mosaic loss of chromosome Y with dermatitis and eczema risk: an analysis in a large-scale prospective cohort study

Clicks: 1
ID: 315042
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #134 of 304 articles by views in the british journal of dermatology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 304 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background Evidence regarding the role of hematopoietic mosaic loss of chromosome Y (mLOY) in incident dermatitis and eczema (DE) risk, and its contribution to male susceptibility remains limited. Objective To evaluate the associations of mLOY with incident DE and to assess whether mLOY may contribute to sex differences in DE susceptibility. Methods This prospective study included 189,572 UK Biobank men free of DE at baseline, recruited between 2006 and 2010. Hematopoietic mLOY was derived from genotyping intensity data and analysed as both categorical mLOY status and continuous mLOY percentage (mLOY%). Cox proportional hazards models were used to estimate associations with incident DE. Sex susceptibility was evaluated in a 1:1 propensity score-matched male–female cohort. Genetic modification was assessed using a DE polygenic risk score (PRS), and mediation by circulating metabolites was explored in the Metabolomics analyses. Results During follow-up, 9,608 men developed DE. In fully adjusted models, both low mLOY (8–20%) and high mLOY (>20%) were associated with increased DE risk, with the strongest association observed for high mLOY [adjusted hazard ratio (aHR) 1.44, 95% CI 1.26–1.66; P <0.001]. Compared with females, males without detectable mLOY had a similar DE risk, whereas males with low mLOY and high mLOY had progressively higher risks (aHR 1.14, 95% CI 1.07–1.21; and aHR 1.52, 95% CI 1.32–1.74, respectively), supporting a contribution of mLOY to male susceptibility. In age–mLOY discordance analyses, younger men with high mLOY showed a DE risk approaching that of older men without high mLOY, consistent with accelerated biological ageing. The greatest risk was observed in men with both high mLOY and high PRS (aHR 1.85, 95% CI 1.49–2.31; P <0.001). In metabolomic analyses, 98 circulating metabolites significantly mediated the mLOY–DE association, predominantly lipoprotein-related traits. Conclusion Hematopoietic mLOY was associated with an increased risk of incident DE and may contribute to late–life sex differences in DE susceptibility. Lipoprotein-centric mediation signals implicate modifiable metabolic pathways and support integrating mLOY status and lipid profiling into risk assessment for older men.
Reference Key
openalex_W7162540713 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Yajia Li, Qiangxiang Li, Ziqin Cao, Yunsheng Liang
Journal the british journal of dermatology
Year 2026
DOI
10.1093/bjd/ljag219
URL
https://doi.org/10.1093/bjd/ljag219
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.